Background: The effectiveness of the 5 US Food and Drug Administration–approved
pharmacologic therapies for dementias in achieving clinically relevant improvements is …

Abstract Background/Aims: There is no consensus regarding the optimal
nonpharmacological intervention to slow down dementia-related decline. We examined …

Objective To investigate the efficacy and safety of nabilone for agitation in patients with
moderate-to-severe Alzheimer's disease (AD). Design This 14-week randomized double …

Background: Randomized clinical trials have evaluated the efficacy of acetylcholinesterase
inhibitors (AChE-Is) and memantine across a wide range of Alzheimer's disease (AD) …

Abstract Introduction Adults with Down syndrome (DS) are at exceptionally high risk for
Alzheimer's disease (AD), with virtually all individuals developing key neuropathological …

Background: Inappropriate prescribing is a well-known clinical problem in nursing home
residents, but few interventions have focused on reducing inappropriate medication use …

Objective To determine the course of neuropsychiatric symptoms (NPSs) in nursing home
residents with dementia and to determine their variability across diagnosis. Design …

Aims: The goal of this study is to assess the relationship between quality of life (QoL),
neuropsychiatric symptoms (NPS), psychotropic drug use (PDU) and patient characteristics …

Introduction The present review of Alzheimer's disease (AD) rating scales aims to outline the
need for a new rating scale to be used in routine clinical practice for long-term medical care …

Dementia: From Diagnosis to Management-A Functional Approach is a comprehensive
description of a functional and behavioral approach to assessing and treating persons with …